Suchergebnisse - "Banach, Maciej"

PubPharm (14)

1

Prevalence of statin intolerance : a meta-analysis

enthalten in: European heart journal | 2022

von Bytyçi, I. | Penson, P. | Mikhailidis, D. | +10

CommentIn: Eur Heart J. 2022 Mar 23;:. - PMID 35325103

2

Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe : DA VINCI observational study

enthalten in: Atherosclerosis | 2021

von Vrablik, M. | Seifert, B. | Parkhomenko, A. | +8

3

EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care : the DA VINCI study

enthalten in: European journal of preventive cardiology | 2021

von Ray, K. | Molemans, B. | Schoonen, W. | +28

4

Nutraceuticals in the Management of Dyslipidemia : Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

enthalten in: Current atherosclerosis reports | 2021

von Cicero, A. | Fogacci, F. | Stoian, A. | +5

5

Impact of nutraceuticals on markers of systemic inflammation : Potential relevance to cardiovascular diseases - A position paper from the International Lipid Expert Panel (ILEP)

enthalten in: Progress in cardiovascular diseases | 2021

von Ruscica, M. | Penson, P. | Ferri, N. | +87

6

How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors

enthalten in: Progress in cardiovascular diseases | 2021

von Cybulska, B. | Kłosiewicz-Latoszek, L. | Penson, P. | +4

7

Lipid levels, atrial fibrillation and the impact of age : Results from the LIPIDOGRAM2015 study

enthalten in: Atherosclerosis | 2020

von Harrison, S. | Lane, D. | Banach, M. | +105

8

High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention : The ARIC Study

enthalten in: Journal of the American Heart Association | 2020

von Quispe, R. | Michos, E. | Martin, S. | +8

9

National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio : a pooled analysis of 458 population-based studies in Asian and Western countries

enthalten in: International journal of epidemiology | 2020

von NCD Risk Factor Collaboration (NCD-RisC) | Taddei, C. | Jackson, R. | +98

10

Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate

enthalten in: BMC medicine | 2016

von Hobbs, F. | Banach, M. | Mikhailidis, D. | +2